Hiba Hamdar | Medicine and Health Sciences | Innovative Research Award

Published on by Top Teachers

Innovative Research Award

Hiba Hamdar, MD — Emergency Medicine Physician, Medical Researcher and HealthTech Innovator, Medical Learning Skills Academy, Germany

Hiba Hamdar
Affiliation Medical Learning Skills Academy
Country Germany
Google Scholar ga_S3XAAAAAJ
Documents 58
Citations 100
h-index 5
Subject Area Artificial Intelligence
Event Top Teachers Awards
Scopus ID 57196075496
ORCID 0000-0002-4488-7323

Hiba Hamdar, MD, is an emergency medicine physician and medical researcher whose professional activities combine clinical medicine, medical education, evidence-based research and health technology. Her academic profile records 58 documents, 100 citations and an h-index of 5. Her work also includes development of technology-supported medical learning environments and research-oriented educational initiatives. [1]

Abstract

Hiba Hamdar is an MD-qualified emergency medicine physician, researcher and health technology innovator with professional experience spanning emergency care, clinical training, medical education and digital health. Her academic activities encompass medical research, systematic review methods, clinical case work and interdisciplinary collaboration. She founded the Medical Learning Skills Academy and developed the MLS Virtual Hospital, an AI-supported clinical training environment designed to provide learners with structured practice in history-taking, diagnosis, investigation interpretation and procedural learning. The project has been deposited in Zenodo and assigned DOI 10.5281/zenodo.20392558. [3]

Keywords

Artificial intelligence; medical education; emergency medicine; digital health; health technology; clinical simulation; machine learning; medical research; evidence-based medicine; Python; Streamlit; clinical decision support.

Introduction

Hiba Hamdar’s professional profile is situated at the intersection of clinical practice, medical education and emerging health technologies. Following her Doctor of Medicine education at the Medical University of Plovdiv, she developed clinical experience in emergency medicine together with rotations and internships in obstetrics and gynecology, hematology, oncology, cardiology, cardiovascular surgery, pediatric surgery and internal medicine. Her stated research interests include academic medicine, abdominal tuberculosis, neurochemical research and other clinical and biomedical subjects.

Her professional activities subsequently expanded toward digital medical education. Through the Medical Learning Skills Academy, she has developed educational programs intended to connect theoretical medical knowledge with practical clinical competencies. This approach includes structured learning in anamnesis, physical examination, electrocardiographic and imaging interpretation, resuscitation, procedural skills and clinical case presentation.

Research Profile

Hiba Hamdar’s research profile combines clinical medicine with health technology and educational innovation. Her documented academic record includes 58 documents, 100 citations and an h-index of 5 and Scopus profile records 22 documents, 74 citations, and an h-index of 5.[1][2] Her research and professional interests cover general and internal medicine, cardiovascular medicine, health care sciences, neurosciences and experimental medicine, while artificial intelligence and digital health represent important components of her technology-oriented work.

Her technical activities include Python programming, Streamlit application development, electronic health record concepts, retrieval-augmented generation systems, artificial-intelligence and large-language-model integration, medical database management, multiple-choice assessment systems and three-dimensional medical visualization. These skills are applied primarily to medical learning and clinical simulation rather than as independent software-development activities.

Her professional service has included editorial, peer-review and guest-editing responsibilities, together with participation in international research collaborations. She has also been involved in a global surgical outcomes collaboration associated with the HIPPO Global Cohort Study and has led the MLS Rare Cases Global Project.

Research Contributions

A central contribution of Hiba Hamdar’s work is the development of medical-learning infrastructure that combines clinical reasoning with interactive technology. The MLS Virtual Hospital uses Python and Streamlit to provide simulated clinical encounters involving patient history-taking, diagnostic reasoning, laboratory and imaging interpretation and procedural learning. Its reported components include a multiple-choice question system, mentor directory, clinical case library, three-dimensional procedure viewer and retrieval-augmented medical knowledge functionality. [3]

Her research contribution also includes participation in clinical and biomedical literature addressing therapeutic applications and systematic evidence synthesis. Examples supplied in her academic record include research concerning medical gases in cancer treatment and systematic evidence regarding the anti-inflammatory effects of mesenchymal stem cells in burns. [4] [5]

Through the MLS Academy, Hamdar further contributes to medical education by integrating practical clinical skills, research literacy and technology competencies into structured learning activities. Her stated objective is to create a continuous pathway from foundational medical training to clinical reasoning, research production and responsible use of artificial intelligence.

Publications

Hiba Hamdar’s publication and editorial activities span clinical medicine, biomedical research, medical education and emerging health technologies. Her profile reports more than 20 peer-reviewed publications and book chapters, together with editorial involvement in books addressing neuroscience, brain-heart connections, artificial intelligence in smart healthcare systems and infectious diseases. Her publication record is indexed through academic research platforms including Google Scholar and Scopus. [1] [2]

Representative research cited in the supplied academic record includes the 2025 article by Al Bazzal and colleagues on potential therapeutic applications of medical gases in cancer treatment and the 2022 systematic review by Eldaly and colleagues examining systemic anti-inflammatory effects of mesenchymal stem cells in burns. These publications illustrate the broader biomedical research context associated with her academic profile. [4] [5]

Research Impact

The available bibliometric information records 100 citations and an h-index of 5 across 58 documents in the supplied profile data. [1] These indicators provide a quantitative description of the visibility of her indexed research but should be interpreted alongside publication quality, research collaboration, methodological contribution and practical relevance.

A distinctive aspect of her current work is the translation of research and clinical knowledge into digital learning environments. The MLS Virtual Hospital represents an applied technology project in which artificial intelligence, software development and clinical education are brought together in a simulation-based setting. Its Zenodo record provides a persistent scholarly reference for the project. [3]

Her participation in international clinical research and editorial activities additionally indicates engagement beyond individual clinical practice. The combination of clinical experience, research participation, medical education and technology development provides a multidisciplinary basis for continued work in AI-enabled healthcare learning.

Award Suitability

For the Innovative Research Award associated with the Top Teachers Awards, Hiba Hamdar’s profile demonstrates several relevant characteristics: an established clinical and research background, documented scholarly output, participation in peer review and editorial activities, and practical development of technology for medical education. Her work on the MLS Virtual Hospital is particularly relevant to an innovation-focused recognition because it connects clinical training with artificial intelligence, interactive simulation and structured digital learning. [3]

The award suitability assessment is supported by the combination of measurable academic indicators and applied educational innovation. Her profile records 58 documents, 100 citations and an h-index of 5, while her professional activities include founding and directing a medical education academy and contributing to digital-health development. [1] These elements provide a substantive basis for consideration within a research and teaching innovation category.

Conclusion

Hiba Hamdar’s academic and professional profile reflects an interdisciplinary trajectory connecting emergency medicine, biomedical research, medical education and artificial intelligence. Her documented research activity, international collaboration, editorial service and development of the MLS Virtual Hospital demonstrate an emphasis on applying technology to structured medical learning. The combination of scholarly activity and practical health-technology development provides a relevant foundation for recognition in an innovative research and education context.[1]

References

  1. Google Scholar. (n.d.). Hiba Hamdar, Google Scholar author profile. https://scholar.google.com/citations?hl=en&user=ga_S3XAAAAAJ
  2. Elsevier. (n.d.). Scopus author details: Hiba Hamdar, Author ID 57196075496. Scopus. https://www.scopus.com/pages/authors/57196075496
  3. Hamdar, H. (2025). MLS Virtual Hospital. Zenodo. DOI: https://doi.org/10.5281/zenodo.20392558
  4. Hamdar, H, Al Bazzal, A., Hoteit, B. H., Chokor, M., Safawi, A., Zibara, Z., Rizk, F., Kawssan, A., et al. (2025). Potential therapeutic applications of medical gases in cancer treatment. Medical Gas Research, 15(2), 309. https://pmc.ncbi.nlm.nih.gov/articles/PMC11918469/
  5. Hamdar, H, Eldaly, A. S., Mashaly, S. M., Fouda, E., Emam, O. S., Aglan, A., Abuasbeh, J., et al. (2022). Systemic anti-inflammatory effects of mesenchymal stem cells in burn: A systematic review of animal studies. Journal of Clinical and Translational Research, 8(4), 276. https://pmc.ncbi.nlm.nih.gov/articles/PMC9389574/

Song Guo Zheng | Medicine and Health Sciences | Best Innovator Award

Published on by Top Teachers

Best Innovator Award

Song Guo Zheng
Shanghai Jiao Tong University, China
Song Guo Zheng
Affiliation Shanghai Jiao Tong University
Country China
Scopus ID 7403146499
Documents 262
Citations 16,675
h-index 75
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-5611-4774
Google Scholar 37kvQ18AAAAJ

Song Guo Zheng is a physician-scientist and immunologist whose academic career has spanned molecular immunology, rheumatology, autoimmunity, cell therapy, and translational medicine. His research has contributed to the understanding of regulatory T cells, immune tolerance, autoimmune disease mechanisms, and therapeutic immunomodulation. He currently serves as Chair Professor of Medicine and Dean of the School of Cell and Gene Therapy at Shanghai Jiao Tong University School of Medicine while maintaining extensive leadership roles in international scientific organizations and scholarly publishing.[1]

Abstract

This article evaluates the academic achievements, scientific leadership, educational service, and innovation record of Song Guo Zheng in relation to the Best Innovator Award. His work integrates fundamental immunology with translational medicine, resulting in influential publications, patents, edited books, international collaborations, and leadership positions across major scientific societies. The breadth of his contributions demonstrates sustained impact on biomedical research and clinical immunology.[1]

Keywords

Rheumatology, Immunology, Autoimmunity, T Regulatory Cells, Cell Therapy, GMSC, Tumor Immunity.

Introduction

Over several decades, Song Guo Zheng has established an interdisciplinary research program focused on immune regulation, autoimmune disease pathogenesis, regenerative medicine, and therapeutic cell engineering. His academic development includes medical training in China, doctoral education in France, and faculty appointments at major institutions in the United States and China. His scientific output has contributed to both theoretical and applied aspects of immunological science.[1]

Research Profile

Song Guo Zheng earned an M.D. from Anhui Medical University and later completed a Ph.D. in Molecular Immunology at the University of Orleans, France. His academic appointments have included leadership roles at the University of Southern California, Penn State University, Ohio State University, and Shanghai Jiao Tong University. He has also served as editor, associate editor, and editorial board member for numerous high-impact journals while participating in major international grant-review panels and scientific committees.[1]

Research Contributions

  • Advanced understanding of regulatory T-cell biology and immune tolerance mechanisms.[2]
  • Developed strategies for immune modulation relevant to autoimmune disorders and inflammatory diseases.[3]
  • Contributed to translational research in cell therapy, tumor immunity, and regenerative medicine.
  • Secured multiple granted patents involving regulatory T cells, exosome applications, and immunotherapeutic technologies.[1]
  • Edited scientific books and chapters that support education and dissemination of immunological knowledge.

Publications

Representative publications include influential studies on regulatory T-cell induction, immune tolerance, vitamin-mediated immune regulation, and chronic disease immunobiology. These works have become widely cited within immunology and rheumatology literature.[2][3][4][5][6]

Research Impact

According to the provided scholarly metrics, the researcher has produced 262 indexed documents, accumulated more than 16,675+ citations, and achieved an h-index of 75. These indicators reflect substantial scholarly visibility and influence within biomedical sciences. His leadership in international societies, conference organization, editorial service, and research mentoring further extends the impact of his work beyond publication metrics alone.[1]

Award Suitability

The Best Innovator Award recognizes individuals who demonstrate sustained innovation, measurable research impact, educational leadership, and translational achievement. Song Guo Zheng’s portfolio includes pioneering immunological discoveries, numerous patents, extensive publication activity, scientific leadership, international recognition, and contributions to medical education. These accomplishments collectively support strong consideration for recognition within innovation-focused academic award programs.[1]

Conclusion

Song Guo Zheng has developed a distinguished career characterized by innovation in immunology, leadership in academic medicine, and contributions to translational biomedical research. His scientific achievements, educational service, publication record, patents, and international professional engagement provide a substantial foundation for recognition under the Best Innovator Award framework.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Song Guo Zheng, Author ID 7403146499. Scopus. https://www.scopus.com/authid/detail.uri?authorId=7403146499
  2. Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA. Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity. The Journal of Immunology. https://doi.org/10.4049/jimmunol.172.9.5213
  3. Huang Z, Liu Y, Qi G, Brand D, Zheng SG. Role of Vitamin A in the Immune System. Journal of Clinical Medicine. https://doi.org/10.3390/jcm7090258
  4. Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA. IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.178.4.2018
  5. Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA. Generation Ex Vivo of TGF-β-Producing Regulatory T Cells. The Journal of Immunology. https://doi.org/10.4049/jimmunol.169.8.4183
  6. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, Zheng SG. Vitamin D and Chronic Diseases. Aging and Disease. https://pmc.ncbi.nlm.nih.gov/articles/PMC5440113/

Ömer Yavuz | Medicine and Health Sciences | Excellence in Research Award

Published on by Top Teachers

Excellence in Research Award

Ömer Yavuz
Başakşehir Çam and Sakura City Hospital, Turkey
Ömer Yavuz
Affiliation Başakşehir Çam and Sakura City Hospital
Country Turkey
Scopus ID 56712503200
Documents 11
Citations 44
h-index 4
Subject Area Medicine and Health Sciences
Event Top Teachers Awards

Ömer Yavuz is a thoracic surgery specialist affiliated with Başakşehir Çam and Sakura City Hospital. He has contributed significantly to thoracic surgery research through clinical investigations, minimally invasive surgical innovations, oncological studies, and multidisciplinary collaborations.[1] His academic profile reflects active participation in peer-reviewed publications, international scientific congresses, educational activities, and collaborative healthcare research initiatives within thoracic and pulmonary medicine. The Excellence in Research Award recognizes his distinguished scholarly achievement, sustained scientific contribution, and professional advancement in the field of medicine and health sciences.[2]

Abstract

Ömer Yavuz is a Turkish thoracic surgery specialist whose academic activities encompass clinical thoracic surgery, pulmonary oncology, minimally invasive surgical procedures, robotic thoracic surgery, and perioperative patient management. His scholarly contributions include peer-reviewed journal publications, conference presentations, collaborative multicenter studies, and educational involvement in thoracic surgery seminars.[3] His research portfolio demonstrates continuing engagement with contemporary surgical techniques and evidence-based clinical practice, particularly in lung cancer surgery, thoracic oncology, port catheter applications, and minimally invasive approaches.[4]

Keywords

Thoracic Surgery, Lung Cancer, Robotic Surgery, Pulmonary Oncology, Minimally Invasive Surgery, Thoracic Oncology, Video-Assisted Thoracoscopic Surgery, Surgical Research, Medical Education, Clinical Research.

Introduction

Thoracic surgery remains an essential subspecialty within medicine, requiring the integration of surgical precision, oncological knowledge, and multidisciplinary clinical coordination. Research in this field contributes to the advancement of minimally invasive interventions, perioperative management, and improved long-term patient outcomes. Within this context, Ömer Yavuz has participated in clinical and academic activities addressing thoracic surgical practice, lung cancer management, robotic-assisted procedures, and rare thoracic disorders.[5]

His professional training includes medical education at Gülhane Military Medical Faculty and specialization in thoracic surgery at Gülhane Military Medical Academy Haydarpaşa Training Hospital. Subsequent clinical appointments at Muş State Hospital, Koç University Hospital, and Başakşehir Çam and Sakura City Hospital contributed to the development of his clinical and academic profile.[6]

Research Profile

The research profile of Ömer Yavuz reflects interdisciplinary collaboration across thoracic surgery, oncology, pathology, and minimally invasive surgical technologies. His publications include clinical analyses, surgical case reports, retrospective investigations, translational research studies, and conference proceedings focused on thoracic diseases and operative outcomes.[7]

Research topics addressed in his work include pectus excavatum surgery, pleurodesis techniques, thoracic oncology, spread through air spaces in lung adenocarcinoma, immune profiling after minimally invasive lobectomy, robotic thoracic surgery, port catheter complications, and bibliometric analyses of surgical literature.[8]

In addition to publication activities, he has participated in national and international scientific congresses, including presentations associated with the World Conference on Lung Cancer, the European Society of Thoracic Surgeons, and Turkish thoracic surgery congresses.[9]

Research Contributions

Ömer Yavuz has contributed to research evaluating minimally invasive surgical procedures and thoracic oncological management. His collaborative study on immune profiling after minimally invasive lobectomy examined postoperative immunological responses following thoracic surgical intervention.[10]

Additional research contributions include investigations into thoracic surgical outcomes during the COVID-19 pandemic, demonstrating the feasibility of elective cancer surgery during periods of healthcare system restriction.[11] Other studies addressed prognostic indicators in lung adenocarcinoma, including spread through air spaces identified through PET/CT imaging modalities.[12]

His more recent research activities involve robotic-assisted thoracic surgery, landmark-based port catheter placement techniques, thoracic outlet syndrome procedures, and perioperative management strategies in low-resource surgical settings.[13] Several accepted publications scheduled for 2026 further demonstrate ongoing academic engagement in thoracic surgical innovation and healthcare research productivity.[14]

  • Research in minimally invasive thoracic surgery and robotic-assisted procedures.
  • Clinical investigations in lung cancer surgery and thoracic oncology.
  • Studies involving perioperative outcomes and surgical feasibility during the COVID-19 pandemic.
  • Development of port catheter placement approaches in resource-limited clinical settings.
  • Participation in multidisciplinary and international thoracic surgery collaborations.

Publications

Ömer Yavuz has contributed to thoracic surgery research through publications focused on minimally invasive surgery, thoracic oncology, robotic-assisted procedures, perioperative management, and pulmonary diseases. His scholarly work includes clinical investigations on lung adenocarcinoma, immune profiling after lobectomy, pleurodesis techniques, hyperhidrosis surgery outcomes, and port catheter complications. He has also participated in multidisciplinary and international collaborative studies published in peer-reviewed medical journals, including research related to COVID-19 surgical management and malignant pleural mesothelioma. These publications demonstrate sustained engagement with evidence-based thoracic surgery, innovative surgical methodologies, and contemporary clinical challenges within medicine and health sciences.

Research Impact

The academic contributions of Ömer Yavuz have supported ongoing discussions related to thoracic surgical techniques, perioperative care, robotic-assisted interventions, and oncological thoracic procedures. His Scopus-indexed publication record demonstrates measurable citation activity and participation in collaborative scientific research.[15]

His involvement in educational seminars and professional associations, including the Turkish Thoracic Society, Turkish Society of Thoracic Surgery, and European Society of Thoracic Surgeons, further reflects sustained engagement with academic medicine and surgical education.[16]

  • Peer-reviewed publications indexed in international academic databases.
  • Conference presentations at national and international thoracic surgery congresses.
  • Research participation in EU Framework Program and TÜBİTAK-supported scientific projects.
  • Ongoing publication activity in robotic thoracic surgery and surgical innovation.
  • Academic teaching contributions within thoracic surgery clinical seminars.

Award Suitability

The scholarly record of Ömer Yavuz demonstrates alignment with the objectives of the Excellence in Research Award presented through the Top Teachers Awards platform. His contributions to thoracic surgery research, publication activity in peer-reviewed journals, participation in international congresses, and involvement in educational and collaborative medical initiatives collectively support recognition for academic and professional achievement.[17]

Particular areas of distinction include minimally invasive thoracic surgery, robotic-assisted surgical techniques, thoracic oncology research, and clinical studies concerning perioperative outcomes and surgical methodologies in varying healthcare settings.[18]

Conclusion

Ömer Yavuz has established an academic and clinical profile characterized by ongoing participation in thoracic surgery research, scientific collaboration, and surgical education. His publication history, conference involvement, and clinical specialization reflect continued engagement with evidence-based thoracic surgical practice and medical research development. The breadth of his scholarly contributions within medicine and health sciences provides a substantial basis for recognition through the Excellence in Research Award.[19]

References

    1. Elsevier. (n.d.). Scopus author details: Ömer Yavuz, Author ID 56712503200. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56712503200
    2. Başakşehir Çam and Sakura City Hospital. (n.d.). Thoracic surgery and clinical research activities.
    3. Yıldızhan, A., Candaş, F. H., Yavuz, Ö., et al. (2015). Experiences with the Nuss Procedure in Young Adult Patients with Pectus Excavatum.DOI: https://doi.org/10.5606/tgkdc.dergisi.2015.10497
    4. Erus, S., Öztürk, A. B., Albayrak, Ö., et al. (2021). Immune Profiling After Minimally Invasive Lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    5. Marazioti, A., et al. (2021). KRAS Signaling in Malignant Pleural Mesothelioma. DOI: https://doi.org/10.15252/emmm.202013631
    6. Curriculum Vitae of Ömer Yavuz. (2026). Professional experience and academic background.
    7. Süer, H., et al. (2023). Combination of CEACAM5, EpCAM and CK19 Gene Expressions in Mediastinal Lymph Node Micrometastasis. DOI: https://doi.org/10.1186/s13019-023-02297-z
    8. Yavuz, Ö., İşcan, M. (2025). Port Catheter Thickness and Its Correlation with Complications – Exploring the Millimeter Threshold. DOI: https://doi.org/10.1186/s13019-025-03817-9
    9. European Society of Thoracic Surgeons. (2022). Conference proceedings and poster presentations.
    10. Interactive CardioVascular and Thoracic Surgery. (2021). Immune profiling after minimally invasive lobectomy. DOI: https://doi.org/10.1093/icvts/ivaa296
    11. Kulle, C. B., et al. (2021). Is Elective Cancer Surgery Feasible During the Lock-Down Period of the COVID-19 Pandemic? DOI: https://doi.org/10.1002/jso.26436
    12. Falay, O., et al. (2021). Prediction of Spread Through Air Spaces with Preoperative 18F-FDG PET/CT in Primary Lung Adenocarcinoma. DOI: https://doi.org/10.1097/MNM.0000000000001414
    13. İşcan, M., Yavuz, Ö. (2026). Uniportal Robotic-Assisted Thoracic Surgery for Anatomical Lung Resections. DOI: https://doi.org/10.20452/wiitm.2026.18021
    14. Current Thoracic Surgery. (2026). Accepted publications in thoracic surgery and bibliometric analysis.
    15. Scopus Database Metrics. (n.d.). Author citation indicators and publication statistics.
    16. Turkish Thoracic Society; Turkish Society of Thoracic Surgery; European Society of Thoracic Surgeons. (n.d.). Professional membership records.
    17. Top Teachers Awards. (n.d.). Excellence in Research Award recognition framework. https://topteachers.net/
    18. CTSNet. (2024–2025). Robotic thoracic surgery and port catheter publications.
    19. Academic Curriculum Documentation. (2026). Teaching activities, conference participation, and scholarly output.